Site-Specific Conjugation of Peptides and Proteins via Rebridging of Disulfide Bonds Using the Thiol-Yne Coupling Reaction.

Herein, we describe an extension of our previously reported photomediated disulfide rebridging methodology to the conjugation of peptides and proteins. The methodology proved to be reproducible with various alkynes and different peptides. This study includes the first rebridging of the disulfide bond of a peptide through a thiol-yne reaction with a cyclooctyne. In all cases, the rebridging was proven by MS analyses and confirmed by the absence of olefinic protons on (1)H NMR spectra of the resulting products. Finally, this one-pot reduction thiol-yne conjugation was successfully applied to an antibody Fab fragment with a promising conversion, which set a good ground for the future syntheses of new protein and antibody conjugates.

[1]  S. Brocchini,et al.  Site-directed chemical modification and cross-linking of a monoclonal antibody using equilibrium transfer alkylating cross-link reagents. , 1990, Bioconjugate chemistry.

[2]  S. Ghosh,et al.  Use of maleimide-thiol coupling chemistry for efficient syntheses of oligonucleotide-enzyme conjugate hybridization probes. , 1990, Bioconjugate chemistry.

[3]  M. Garnett,et al.  Targeted drug conjugates: principles and progress. , 2001, Advanced drug delivery reviews.

[4]  M. Bentley,et al.  Chemistry for peptide and protein PEGylation. , 2002, Advanced drug delivery reviews.

[5]  Virginia W Cornish,et al.  Selective chemical labeling of proteins in living cells. , 2005, Current opinion in chemical biology.

[6]  Anna M Wu,et al.  Arming antibodies: prospects and challenges for immunoconjugates , 2005, Nature Biotechnology.

[7]  Yelena Kovtun,et al.  Semisynthetic maytansine analogues for the targeted treatment of cancer. , 2006, Journal of medicinal chemistry.

[8]  K. Anseth,et al.  Synthesis of cyclic, multivalent Arg-Gly-Asp using sequential thiol-ene/thiol-yne photoreactions. , 2010, Chemical communications.

[9]  C. Bowman,et al.  Reaction Rates and Mechanisms for Radical, Photoinitated Addition of Thiols to Alkynes, and Implications for Thiol−Yne Photopolymerizations and Click Reactions , 2010 .

[10]  C. J. O’Donnell,et al.  Investigational antibody drug conjugates for solid tumors , 2011, Expert opinion on investigational drugs.

[11]  G. Pruijn,et al.  Preventing thiol-yne addition improves the specificity of strain-promoted azide-alkyne cycloaddition. , 2012, Bioconjugate chemistry.

[12]  F. Veronese,et al.  The Impact of PEGylation on Biological Therapies , 2012, BioDrugs.

[13]  Thomas H Pillow,et al.  Antibody‐Drug Conjugates for the Treatment of Cancer , 2013, Chemical biology & drug design.

[14]  Carlo P Ramil,et al.  Bioorthogonal chemistry: strategies and recent developments. , 2013, Chemical communications.

[15]  Brian J. Adzima,et al.  A novel copper containing photoinitiator, copper(II) acylphosphinate, and its application in both the photomediated CuAAC reaction and in atom transfer radical polymerization. , 2013, Chemical communications.

[16]  L. Jones,et al.  Biotherapeutics: Recent Developments using Chemical and Molecular Biology , 2013 .

[17]  James R. Baker,et al.  Homogeneous antibody fragment conjugation by disulfide bridging introduces ‘spinostics' , 2013, Scientific Reports.

[18]  En-Wei Lin,et al.  Therapeutic protein-polymer conjugates: advancing beyond PEGylation. , 2014, Journal of the American Chemical Society.

[19]  P. Strop,et al.  World Antibody-Drug Conjugate Summit, October 15–16, 2013, San Francisco, CA , 2013, mAbs.

[20]  R. Chari,et al.  Antibody-drug conjugates: an emerging concept in cancer therapy. , 2014, Angewandte Chemie.

[21]  Peter G Schultz,et al.  A general approach to site-specific antibody drug conjugates , 2014, Proceedings of the National Academy of Sciences.

[22]  S. Bräse,et al.  Application of a novel small scale UV LED photochemical batch reactor for the thiol-yne reaction , 2015 .